Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Making a good thing last: the effect of intravenous hydrocortisone premedication on the immunogenicity of infliximab.

Making a good thing last: the effect of intravenous hydrocortisone premedication on the immunogenicity of infliximab. Inflamm Bowel Dis. 2003 Sep; 9(5):339-40.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.